Miltefosine - CAS# 58066-85-6 Catalog No.:M11118-10 daily for 5 days) suppresses

daily for 5 days) suppresses the transcription of influenza viruses (IFV) -associated inflammatory cytokines

It needs to be taken only once a day

>5000 mg/kg bwt by the dermal route

and competitive antagonist of BET bromodomains to hijack the Cereblon E3 ubiquitin ligase complex

Chaudhuri D

Miltefosine - CAS# 58066-85-6 Catalog No.:M11118-10 daily for 5 days) suppressesMiltefosine is an orally and topically active alkyl phosphocholine compound with potential antineoplastic activity. Miltefosine targets cellular membranes, modulating cell membrane permeability, membrane lipid composition, phospholipid metabolism, and mitogenic signal transduction, resulting in cell differentiation and inhibition of cell growth. This agent also inhibits the anti apoptotic mitogen activated protein kinase (MAPK) pathway and modulates